Recently, Tanizaki and colleagues identified the EGF-mediated activation of HER family signaling as a mechanism driving such resistance by establishing lines of EML4-ALK–positive H3122 lung cancer cells resistant to the ALK inhibitor TAE684 (H3122/TR cells) [67]. This evidence concerns the gene ALK and lung carcinoma.